Table 4.
Organism/Infection | Episodes Occurring 1–30 Days After UCBTa (n = 30) |
Episodes Occurring 30–100 Days After UCBTa (n = 18) |
Episodes Occurring >100 Days After UCBTa (n = 34) |
Total Episodes |
---|---|---|---|---|
Coagulase-negative Staphylococcus BSI | 8 | 6 | 7 | 21 |
van-R Enterococcus | 9 | 5 | 5 | 19 |
Bacteremia | 4 | 3 | 3 | 10 |
UTI | 5 | 2 | 1 | 8 |
Intraabdominal | 0 | 0 | 1 | 1 |
Enterobacteriaceae b | 2 | 3 | 9 | 14 |
Bacteremia | 1 | 2 | 2 | 5 |
UTI | 1 | 1 | 7 | 9 |
Pseudomonas species | 1 | 0 | 4 | 5 |
Bacteremia | 0 | 0 | 2 | 2 |
Pneumonia | 1 | 0 | 1 | 2 |
UTI | 0 | 0 | 1 | 1 |
Other BSIc | 3 | 4 | 1 | 8 |
Clostridium difficile infection | 10 | 4 | 7 | 21 |
Tuberculosis | 0 | 1 | 0 | 1 |
NTM pneumonia | 0 | 1 | 2 | 3 |
Abbreviations: BSI, bloodstream infection; NTM, nontuberculous mycobacterium (includes Mycobacterium chelonae, Mycobacterium abscessus, and Mycobacterium avium); UTI, urinary tract infection; van-R, vancomycin resistant.
aPatients often had more than 1 infection per episode.
bIncludes Escherichia coli, Klebsiella spp, Citrobacter spp, Enterobacter spp, and Proteus spp.
cIncludes Acinetobacter baumanii (n = 3), Clostridium perfringens (n = 1), Micrococcus spp (n = 1), and Streptococcus spp (n = 3).